“Elevai Labs’ growth is a testament to the thriving biotech ecosystem in Greater Sacramento.”

In 2020, Braeden Lichti co-founded and invested into Elevai Labs and lead the company to IPO and eventual sale in 2024. Through his investment the company was able to build a strong foundation in California regenerative aesthetics, ultimately being recognized by regional economic leaders as a biotech success story. Watch the full feature by the Greater Sacramento Economic Council.

Braeden Lichti and Northstrive Team Celebrates PMGC Holdings Listing On Nasdaq